NIH Clinical Center: Search the Studies

Search the Studies

27 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.

Protocol Number	Title	Protocol Status	Min-Max Age	Institute	Keywords
000740-CH	A Phase 3 Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Chronocort in the Treatment of Participants Aged 16 Years and Over with Congenital Adrenal Hyperplasia	Enrolling by Invitation	18-125 Years	NICHD	Congenital
000494-DK	Natural History of Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment	Participants currently recruited/enrolled	18-125 Years	NIDDK	Congenital
000411-CC	A Feasibility Pilot Study of a Virtual Education-Based Transition Intervention to Improve Transition Readiness in Adolescent and Young Adults with Congenital Adrenal Hyperplasia.	Recruitment has not started	16-22 Years	CC	Congenital
000310-CH	A Phase 1/2, First-in-Human, Open-Label, Dose-Escalation Study of the Safety and Efficacy of Gene Therapy for Congenital Adrenal Hyperplasia through Administration of an Adeno-Associated Virus (AAV) Serotype 5-Based Recombinant Vector Encoding the Human	Recruitment has not started	18-125 Years	NICHD	Congenital
000297-CH	A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecerfont (NBI-74788) in Adult Subjects with Classic Congenital Adrenal Hyperplasia, Followed by Open-Label Treatment	Participants currently recruited/enrolled	18-125 Years	NICHD	Congenital
000236-I	A Phase 1 Study of Empagliflozin as Treatment for Severe Congenital Neutropenia Due to G6PC3 Deficiency	Participants currently recruited/enrolled	18-125 Years	NIAID	Congenital
20-CH-0126	Data Collection Study of Pediatric and Adolescent Gynecology Conditions	Participants currently recruited/enrolled	0-125 Years	NICHD	Congenital
20-C-0070	A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Patients with Inborn Errors of Immunity	Participants currently recruited/enrolled	4-69 Years	NCI	Congenital
19-CH-0020	A Phase 1-2 Multi-Center Study to Assess the Efficacy and Safety of Abiraterone Acetate as Adjunctive Therapy in Pre-Pubescent Children with Classic 21-Hydroxylase Deficiency	Recruitment has not started	2-9 Years	NICHD	Congenital
19-C-0085	Phase II Trial of Allogeneic Hematopoietic Cell Transplantation for Peripheral T cell Lymphoma	Clinical hold/Recruitment or enrollment suspended	12-125 Years	NCI	Congenital
18-C-0135	Phase II Trial of Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation	Participants currently recruited/enrolled	4-125 Years	NCI	Congenital
17-H-0095	Heart Catheterization Using Magnetic Resonance Imaging (MRI) Fluoroscopy and Passive Guidewires	Participants currently recruited/enrolled	18-125 Years	NHLBI	Congenital
16-CH-0164	A Phase III Extension Study of Efficacy, Safety and Tolerability of Chronocort (Registered) in the Treatment of Congenital Adrenal Hyperplasia	Completed Study; data analyses ongoing	18-80 Years	NICHD	Congenital
16-C-0003	Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies	Participants currently recruited/enrolled	4-75 Years	NCI	Congenital
15-DK-0108	Natural History of Noncirrhotic Portal Hypertension	Participants currently recruited/enrolled	12-125 Years	NIDDK	Congenital
14-HG-0071	Clinical and Basic Investigations into Known and Suspected Congenital Disorders of Glycosylation	Participants currently recruited/enrolled	1-80 Years	NHGRI	Congenital
14-HG-0055	Study on Moebius Syndrome and Other Congenital Facial Weakness Disorders	Completed Study; data analyses ongoing	2-80 Years	NHGRI	Congenital
14-EI-0064	Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye Conditions	Participants currently recruited/enrolled	1-125 Years	NEI	Congenital
10-HG-0065	Whole Genome Medical Sequencing for Gene Discovery	Participants currently recruited/enrolled	0-125 Years	NHGRI	Congenital
09-H-0225	Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Severe Congenital Anemias Including Sickle Cell Disease and Beta-Thalassemia	No longer recruiting/follow-up only	2-125 Years	NHLBI	Congenital
08-C-0130	A Phase II Trial of Peginterferon alfa-2b (PEG-Intron) for Neurofibromatosis Type 1 Related Unresectable, Symptomatic or Life-Threatening Plexiform Neurofibromas	Completed Study; data analyses ongoing	0-21 Years	NCI	Congenital
06-CH-0011	Natural History Study of Patients with Excess Androgen	Participants currently recruited/enrolled	0-99 Years	NICHD	Congenital
03-H-0170	Nonmyeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation For Severe Congenital Anemias Including Sickle Cell Disease (SCD) and Beta-Thalassemia	Participants currently recruited/enrolled	2-125 Years	NHLBI	Congenital
02-C-0052	Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study	Participants currently recruited/enrolled	0-125 Years	NCI	Congenital
96-CH-0033	An Open, Randomized, Long-Term Clinical Trial of Flutamide, Testolactone, and Reduced Hydrocortisone Dose vs. Conventional Treatment of Children with Congenital Adrenal Hyperplasia	No longer recruiting/follow-up only	2-18 Years	NICHD	Congenital
94-HG-0132	The Phenotype and Etiology of Proteus Syndrome	Participants currently recruited/enrolled	0-125 Years	NHGRI	Congenital
89-M-0006	Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers	Participants currently recruited/enrolled	3-125 Years	NIMH	Congenital